Imago Biosciences Inc (IMGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,911 | -30,135 | -16,394 | -42,311 | -27,585 |
| Depreciation Amortization | -780 | -198 | -71 | 115 | 127 |
| Accounts payable and accrued liabilities | 439 | -875 | -134 | 2,062 | 501 |
| Other Working Capital | 3,931 | -46 | 3,594 | 208 | -430 |
| Other Operating Activity | 4,319 | 3,968 | 1,485 | 163 | 915 |
| Operating Cash Flow | $-39,002 | $-27,286 | $-11,520 | $-39,763 | $-26,472 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -2 |
| Purchase Of Investment | -156,587 | -90,799 | -41,561 | -208,422 | -131,088 |
| Sale Of Investment | 191,660 | 129,160 | 49,660 | 79,153 | 62,903 |
| Investing Cash Flow | $35,073 | $38,361 | $8,099 | $-129,269 | $-68,187 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 837 | 471 | 454 | 164,247 | 163,857 |
| Other Financing Activity | -841 | 0 | 0 | -3,255 | -3,255 |
| Financing Cash Flow | $-4 | $471 | $454 | $160,992 | $160,602 |
| Beginning Cash Position | 11,226 | 11,226 | 11,226 | 19,266 | 19,266 |
| End Cash Position | 7,293 | 22,772 | 8,259 | 11,226 | 85,209 |
| Net Cash Flow | $-3,933 | $11,546 | $-2,967 | $-8,040 | $65,943 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,002 | -27,286 | -11,520 | -39,763 | -26,472 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -2 |
| Free Cash Flow | -39,002 | -27,286 | -11,520 | -39,763 | -26,474 |